JP2002520416A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002520416A5 JP2002520416A5 JP2000560130A JP2000560130A JP2002520416A5 JP 2002520416 A5 JP2002520416 A5 JP 2002520416A5 JP 2000560130 A JP2000560130 A JP 2000560130A JP 2000560130 A JP2000560130 A JP 2000560130A JP 2002520416 A5 JP2002520416 A5 JP 2002520416A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- group
- general formula
- optionally substituted
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 description 24
- -1 amino acid ester Chemical class 0.000 description 8
- 125000003118 aryl group Chemical group 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 5
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 125000001072 heteroaryl group Chemical group 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 125000000547 substituted alkyl group Chemical group 0.000 description 4
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 description 3
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 3
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 3
- 125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 description 3
- 241000224016 Plasmodium Species 0.000 description 3
- 241000223960 Plasmodium falciparum Species 0.000 description 3
- 125000000304 alkynyl group Chemical group 0.000 description 3
- 125000003710 aryl alkyl group Chemical group 0.000 description 3
- 125000000753 cycloalkyl group Chemical group 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000006806 disease prevention Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 125000005843 halogen group Chemical group 0.000 description 3
- 125000000623 heterocyclic group Chemical group 0.000 description 3
- 125000004415 heterocyclylalkyl group Chemical group 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 3
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 3
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 125000003107 substituted aryl group Chemical group 0.000 description 2
- 239000007818 Grignard reagent Substances 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 230000036281 parasite infection Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98305596.3 | 1998-07-14 | ||
| EP98305596 | 1998-07-14 | ||
| PCT/GB1999/002267 WO2000004024A1 (en) | 1998-07-14 | 1999-07-14 | Antiparasitic artemisinin derivatives (endoperoxides) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002520416A JP2002520416A (ja) | 2002-07-09 |
| JP2002520416A5 true JP2002520416A5 (enExample) | 2006-08-24 |
Family
ID=8234942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000560130A Pending JP2002520416A (ja) | 1998-07-14 | 1999-07-14 | 寄生虫に作用するアルテミシニン誘導体（エンドペルオキシド類） |
Country Status (27)
| Country | Link |
|---|---|
| US (4) | US6984640B1 (enExample) |
| EP (2) | EP1655302A3 (enExample) |
| JP (1) | JP2002520416A (enExample) |
| KR (1) | KR100640113B1 (enExample) |
| CN (1) | CN1122035C (enExample) |
| AT (1) | ATE314373T1 (enExample) |
| AU (1) | AU765860B2 (enExample) |
| BG (1) | BG105137A (enExample) |
| BR (1) | BR9912810A (enExample) |
| CA (1) | CA2337119A1 (enExample) |
| DE (1) | DE69929203T2 (enExample) |
| DK (1) | DK1095042T5 (enExample) |
| ES (1) | ES2257062T4 (enExample) |
| HK (1) | HK1040709B (enExample) |
| HU (1) | HUP0102851A3 (enExample) |
| IL (1) | IL140402A0 (enExample) |
| NO (1) | NO20010223L (enExample) |
| NZ (1) | NZ509324A (enExample) |
| PL (1) | PL345503A1 (enExample) |
| PT (1) | PT1095042E (enExample) |
| RU (1) | RU2236413C2 (enExample) |
| SI (1) | SI1095042T1 (enExample) |
| SK (1) | SK542001A3 (enExample) |
| TR (1) | TR200100073T2 (enExample) |
| UA (1) | UA75325C2 (enExample) |
| WO (1) | WO2000004024A1 (enExample) |
| YU (1) | YU2101A (enExample) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9912810A (pt) * | 1998-07-14 | 2001-05-02 | Bayer Ag | Derivados artemisinina (endoperóxidos) antiparasìticos |
| WO2003076446A1 (en) * | 2002-03-08 | 2003-09-18 | Bayer Business Services Gmbh | Antiparasitic artemisinin derivatives (endoperoxides) |
| DE102004027871B3 (de) * | 2004-06-08 | 2006-03-16 | Lanxess Deutschland Gmbh | Verfahren zur Herstellung von 10α-[4'-(S,S-Dioxothiomorpholin-1'-yl)]-10-desoxo-10-dihydroartemisinin |
| EP1714967A1 (en) * | 2005-04-22 | 2006-10-25 | Bayer HealthCare AG | Antiparasitic artemisinin derivatives |
| US8431611B2 (en) | 2006-10-20 | 2013-04-30 | Johns Hopkins University | Artemisinin derivatives |
| US8193376B2 (en) | 2007-01-01 | 2012-06-05 | Bioderm Research | Artemisinin derivatives with natural amino acids, peptides, and amino sugars for the treatment of infection and topical condition in mammals |
| GB0720967D0 (en) * | 2007-10-25 | 2007-12-05 | Protophama Ltd | Anti-material pharmaceutical composition |
| JP5438098B2 (ja) * | 2008-04-29 | 2014-03-12 | ノバルティス アーゲー | 寄生虫性疾患の処置のためのスピロ−インドール誘導体 |
| PT2424523E (pt) * | 2009-04-23 | 2012-10-03 | Londonpharma Ltd | Formulação de spray sublingual compreendendo dihidroartemesinina |
| US8815942B2 (en) | 2010-10-20 | 2014-08-26 | The Royal Institution For The Advancement Of Learning/Mcgill University | Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease |
| RU2466133C1 (ru) * | 2011-06-24 | 2012-11-10 | ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ НАУКИ ИНСТИТУТ ОРГАНИЧЕСКОЙ ХИМИИ им. Н.Д. ЗЕЛИНСКОГО РОССИЙСКОЙ АКАДЕМИИ НАУК (ИОХ РАН) | Трициклические органические монопероксиды и способ их получения |
| EP2770985A4 (en) | 2011-10-25 | 2015-01-21 | U S Phytotherapy Inc | ARTEMISININE AND BERBERINE COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF |
| US9358261B2 (en) | 2011-10-25 | 2016-06-07 | U.S. Phytotherapy, Inc. | Additional artemisinin and berberine compositions and methods of making |
| US9675582B2 (en) | 2011-10-25 | 2017-06-13 | U.S. Phytotherapy, Inc. | Alternative ACT with natural botanical active GRAS ingredients for treatment and prevention of the Zika virus |
| BR112014026158A2 (pt) * | 2012-04-18 | 2017-06-27 | Hadasit Med Res Service | métodos e composições para o tratamento de infecções virais |
| JP5994059B2 (ja) * | 2012-09-05 | 2016-09-21 | 国立大学法人東京農工大学 | 抗マラリア活性を有するアザアルテミシニン誘導体及びその製造方法 |
| EP3450549B1 (en) * | 2012-10-29 | 2020-09-30 | University Of Rochester | Artemisinin derivatives, methods for their preparation and their use as antimalarial agents |
| WO2015041722A1 (en) | 2013-09-17 | 2015-03-26 | Kryptonite Group, Ltd | Enhanced artemisinin-based combination therapy for treating parasitic mediated disease |
| USD730736S1 (en) | 2013-10-03 | 2015-06-02 | Gk Packaging, Inc. | Bottle |
| USD729631S1 (en) | 2013-10-03 | 2015-05-19 | Gk Packaging, Inc. | Bottle |
| USD729632S1 (en) | 2013-10-03 | 2015-05-19 | Gk Packaging, Inc. | Bottle |
| USD726544S1 (en) | 2013-11-04 | 2015-04-14 | Gk Packaging, Inc. | Bottle |
| USD727160S1 (en) | 2013-11-04 | 2015-04-21 | Gk Packaging, Inc. | Bottle |
| USD726543S1 (en) | 2013-11-04 | 2015-04-14 | Gk Packaging, Inc. | Bottle |
| USD726545S1 (en) | 2013-11-04 | 2015-04-14 | Gk Packaging, Inc. | Bottle |
| CN103664982A (zh) * | 2013-12-06 | 2014-03-26 | 湖南科源生物制品有限公司 | 青蒿素类似物及其制备方法 |
| CN103896960A (zh) * | 2014-01-14 | 2014-07-02 | 李学强 | 一种高效、绿色的青蒿砜制备方法 |
| USD740677S1 (en) | 2014-03-26 | 2015-10-13 | Gk Packaging, Inc. | Bottle |
| USD740125S1 (en) | 2014-03-26 | 2015-10-06 | Gk Packaging, Inc. | Bottle |
| USD742748S1 (en) | 2014-06-13 | 2015-11-10 | Gk Packaging, Inc. | Bottle |
| USD753502S1 (en) | 2014-09-25 | 2016-04-12 | Gk Packaging, Inc. | Bottle |
| USD753503S1 (en) | 2014-09-25 | 2016-04-12 | Gk Packaging, Inc. | Bottle |
| USD746145S1 (en) | 2014-12-04 | 2015-12-29 | GK Packaging, Inc | Bottle |
| USD784820S1 (en) | 2015-02-05 | 2017-04-25 | Gk Packaging, Inc. | Bottle |
| CN105198898A (zh) * | 2015-09-23 | 2015-12-30 | 山东大学（威海） | 一种用于预防和/或治疗癌症的化合物 |
| USD774914S1 (en) | 2015-10-13 | 2016-12-27 | Gk Packaging, Inc. | Bottle |
| USD807190S1 (en) | 2015-10-13 | 2018-01-09 | Gk Packaging, Inc. | Bottle |
| USD784821S1 (en) | 2015-10-13 | 2017-04-25 | Gk Packaging, Inc. | Bottle |
| USD806555S1 (en) | 2017-03-15 | 2018-01-02 | Gk Packaging, Inc. | Bottle |
| IL269390B (en) | 2017-03-20 | 2022-08-01 | Broad Inst Inc | Compounds and methods for the treatment of parasitic diseases |
| USD825342S1 (en) | 2017-06-02 | 2018-08-14 | Gk Packaging, Inc. | Bottle |
| WO2019180708A1 (en) * | 2018-03-22 | 2019-09-26 | Hadasit Medical Research Services And Development Ltd. | Methods and synergic compositions for treating viral infections |
| USD908011S1 (en) | 2019-04-30 | 2021-01-19 | Gk Packaging, Inc. | Bottle |
| CN110448552B (zh) * | 2019-08-23 | 2023-05-12 | 西南大学 | 二氢青蒿素衍生物在制备抗疟药物中的应用 |
| CN110483547B (zh) * | 2019-08-28 | 2022-08-16 | 西南大学 | 二氢青蒿素的简单酚类偶联物、合成方法及应用 |
| CN110642869B (zh) * | 2019-09-26 | 2022-03-15 | 西南大学 | 二氢青蒿素的硫醚、亚砜与砜衍生物及其应用 |
| USD883798S1 (en) | 2019-09-30 | 2020-05-12 | Gk Packaging, Inc. | Bottle |
| CN114276365B (zh) * | 2021-12-30 | 2023-06-13 | 威胜生物医药(苏州)股份有限公司 | 一种蒿甲醚杂质脱水双氢青蒿素的制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225427A (en) | 1988-10-04 | 1993-07-06 | Hoechst Aktiengesellschaft | 10-substituted ether derivatives of dihydroartemisinin, process for their preparation and their use as antiprotozoal agents |
| EP0362730A1 (en) * | 1988-10-04 | 1990-04-11 | Hoechst Aktiengesellschaft | Artemisinin derivatives, processes for their preparation and their use as antiprotozoal agents |
| RU2098407C1 (ru) * | 1989-09-27 | 1997-12-10 | Рон-Пуленк Рорер С.А. | Способ получения пероксиацетальлактонового соединения (варианты) и лактон |
| CN1028294C (zh) | 1989-12-21 | 1995-04-26 | 中国科学院上海药物研究所 | 一类含氮青蒿素衍生物的合成 |
| TW198722B (enExample) | 1990-05-07 | 1993-01-21 | Hoechst Ag | |
| US5225562A (en) * | 1990-08-10 | 1993-07-06 | Mcchesney James D | Method of preparing (+)-deoxoartemisinin and selected analogues of (+)-deoxoartemisinin |
| JPH07500325A (ja) * | 1991-10-14 | 1995-01-12 | ザ ユニバーシティ オブ シドニー | 環状パーオキシアセタール化合物 |
| JPH05203550A (ja) * | 1992-01-24 | 1993-08-10 | Shimadzu Corp | 界面強度測定方法及びその測定装置 |
| CN1049435C (zh) * | 1994-11-09 | 2000-02-16 | 中国科学院上海药物研究所 | 含苯基和杂环基的青蒿素衍生物及其制备方法 |
| CA2229718A1 (en) * | 1995-08-24 | 1997-03-06 | David J. Mathre | Process for the preparation of imidazolyl macrolide immunosuppressants |
| US6160004A (en) * | 1997-12-30 | 2000-12-12 | Hauser, Inc. | C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities |
| BR9912810A (pt) * | 1998-07-14 | 2001-05-02 | Bayer Ag | Derivados artemisinina (endoperóxidos) antiparasìticos |
| US6649647B1 (en) | 1998-07-14 | 2003-11-18 | Richard Haynes | Trioxane derivatives |
-
1999
- 1999-07-14 BR BR9912810-1A patent/BR9912810A/pt not_active IP Right Cessation
- 1999-07-14 EP EP05017342A patent/EP1655302A3/en not_active Withdrawn
- 1999-07-14 WO PCT/GB1999/002267 patent/WO2000004024A1/en not_active Ceased
- 1999-07-14 SK SK54-2001A patent/SK542001A3/sk unknown
- 1999-07-14 PL PL99345503A patent/PL345503A1/xx not_active Application Discontinuation
- 1999-07-14 JP JP2000560130A patent/JP2002520416A/ja active Pending
- 1999-07-14 US US09/743,827 patent/US6984640B1/en not_active Expired - Lifetime
- 1999-07-14 DE DE69929203T patent/DE69929203T2/de not_active Expired - Fee Related
- 1999-07-14 AU AU49218/99A patent/AU765860B2/en not_active Ceased
- 1999-07-14 YU YU2101A patent/YU2101A/sh unknown
- 1999-07-14 PT PT99933043T patent/PT1095042E/pt unknown
- 1999-07-14 TR TR2001/00073T patent/TR200100073T2/xx unknown
- 1999-07-14 ES ES99933043T patent/ES2257062T4/es not_active Expired - Lifetime
- 1999-07-14 EP EP99933043A patent/EP1095042B9/en not_active Expired - Lifetime
- 1999-07-14 HU HU0102851A patent/HUP0102851A3/hu unknown
- 1999-07-14 AT AT99933043T patent/ATE314373T1/de not_active IP Right Cessation
- 1999-07-14 CN CN99810650A patent/CN1122035C/zh not_active Expired - Lifetime
- 1999-07-14 UA UA2001021049A patent/UA75325C2/uk unknown
- 1999-07-14 NZ NZ509324A patent/NZ509324A/en unknown
- 1999-07-14 RU RU2001104417/04A patent/RU2236413C2/ru not_active IP Right Cessation
- 1999-07-14 IL IL14040299A patent/IL140402A0/xx unknown
- 1999-07-14 KR KR1020017000572A patent/KR100640113B1/ko not_active Expired - Fee Related
- 1999-07-14 DK DK99933043T patent/DK1095042T5/da active
- 1999-07-14 CA CA002337119A patent/CA2337119A1/en not_active Abandoned
- 1999-07-14 SI SI9930873T patent/SI1095042T1/sl unknown
- 1999-07-14 HK HK02102362.4A patent/HK1040709B/zh not_active IP Right Cessation
-
2001
- 2001-01-10 BG BG105137A patent/BG105137A/xx unknown
- 2001-01-12 NO NO20010223A patent/NO20010223L/no unknown
-
2006
- 2006-01-09 US US11/329,297 patent/US7452915B2/en not_active Expired - Fee Related
- 2006-01-09 US US11/329,275 patent/US20060287305A1/en not_active Abandoned
- 2006-01-09 US US11/329,274 patent/US7439238B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002520416A5 (enExample) | ||
| JP2005519908A5 (enExample) | ||
| JP2008509187A5 (enExample) | ||
| RU2005108133A (ru) | Дипептиднитрильные ингибиторы катепсина к | |
| JP2003532731A5 (enExample) | ||
| JP2007507494A5 (enExample) | ||
| JP2007501809A5 (enExample) | ||
| JP2017531038A5 (enExample) | ||
| RU94045155A (ru) | Способы ингибирования болезни альцгеймера | |
| JP2009504763A5 (enExample) | ||
| DK0975595T3 (da) | Kokainanaloger | |
| JP2005097323A5 (enExample) | ||
| AU9189301A (en) | Use of substituted imidazo(1,2-A)pyridine-, imidazo(1,2-A)pyrimidine and imidazo(1,2-A)pyrazine-3-YL-amine derivatives for producing NOS-inhibiting medicaments | |
| AU2018203612A1 (en) | High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions | |
| JP2004514663A5 (enExample) | ||
| JP2020507589A5 (enExample) | ||
| RU2007101653A (ru) | Производные 1-азабицикло[3.3.1]нонанов | |
| TW200738698A (en) | Organic compounds | |
| JP2002527414A5 (enExample) | ||
| JP2018507257A5 (enExample) | ||
| JP2003502367A5 (enExample) | ||
| JP2005508341A5 (enExample) | ||
| JP2004525178A5 (enExample) | ||
| ES2488821T3 (es) | Proceso de preparación de un compuesto antiviral | |
| RU2010147826A (ru) | Ацилоксиалкилкарбаматные пролекарства, способы синтеза и применение |